This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the relative and absolute effects of different antibody preparations (except IL2Ra) when used as induction therapy in kidney transplant recipients.
To determine how the benefits and adverse events vary for each antibody preparation.
To determine how the benefits and harms vary for different formulations of antibody preparation.
To determine whether the benefits and harms vary in specific subgroups of recipients (e.g. children and sensitised recipients).